Use of estriol for treating climacteric osteoporosis

Details Use of estriol for treating climacteric osteoporosis Use of estriol for treating climacteric osteoporosis

A - Human Necessities

61

K

A61K 31/565 (2006.01) A61K 9/70 (2006.01)

Patent

CA 2131822

The invention relates to the use of estriol as the sole active ingredient for the production of a transdermal medicament which continuously releases the active ingredient for the treatment of climacteric osteoporosis. It has been shown according to the invention that estriol, which has up until now been thought ineffective for the treatment of climacteric osteoporosis, develops strong anti-osteoporotic effectiveness upon continuous transdermal application.

Affiliated with

Also associated with

Rating

Use of estriol for treating climacteric osteoporosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of estriol for treating climacteric osteoporosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of estriol for treating climacteric osteoporosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1406014